Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 16 Jan 2025

Long-term disease control in dedifferentiated liposarcoma: a case report on trabectedin priming followed by PD-1 inhibition

in Cancer Immunity and Immunotherapy

Johannes M. Waldschmidt
Lukas Haug
Christine Riedhammer
Christoph K. W. Deinzer
Marcus Zimmermann
Anke Heidemeier
Peter Raab
Maximilian Rudert
Anne Hendricks
Johan F. Lock

Frontiers in Oncology

doi 10.3389/fonc.2024.1518775

201 views

Original Research

Accepted on 15 Jan 2025

Unveiling the Multifaceted Role of CXCL1 in Ovarian Cancer, Atherosclerosis, and Valvular Calcification: An Integrated Bioinformatics Perspective

in Cancer Immunity and Immunotherapy

Qin Fajian
Li Keran
Yan Rui
Weiping Li
Ding Xueyuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1540298

Review

Published on 14 Jan 2025

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1531219

116 views

Case Report

Accepted on 13 Jan 2025

Low Dose Radiation Reverses Pembrolizumab Resistance in Melanoma: Case Report

in Cancer Immunity and Immunotherapy

Ka Hey Agnes Fong
Isaac Ho
Tsz Him So

Frontiers in Oncology

doi 10.3389/fonc.2025.1483117

Case Report

Accepted on 13 Jan 2025

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to Tislelizumab: a case report

in Cancer Immunity and Immunotherapy

Chang Jiang
Shanxian Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1385794

Case Report

Accepted on 13 Jan 2025

Dramatic Response of Advanced Pulmonary Sarcomatoid Carcinoma to Tislelizumab Combined with Anlotinib: A Case Report

in Cancer Immunity and Immunotherapy

Ran-ran Li
Xi-liang Di
Yuan Li
Hao Li
CHonghua Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1531700

Original Research

Accepted on 10 Jan 2025

Development and validation of a machine learning model to predict the risk of lymph node metastasis in early-stage supraglottic laryngeal cancer

in Cancer Immunity and Immunotherapy

Hongyu Wang
Zhiqiang He
Jiayang Xu
Ting Chen
Jingtian Huang
Lihong Chen
Xin Yue

Frontiers in Oncology

doi 10.3389/fonc.2025.1525414

179 views

Original Research

Published on 10 Jan 2025

CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment

in Cancer Immunity and Immunotherapy

Tingting Du
Jialin Zou
Yunying Yang
Honghui Xie
Hui Pang
Wenquan Zhuang
Shutong Wang
Guangyan Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1528138

226 views

Original Research

Published on 10 Jan 2025

Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker

in Cancer Immunity and Immunotherapy

Wenya Xing
Yuanzi Zhou
Qiuzi Long
Nan Yi
Gaoyuan Wang
Rongwei Shi
Jinlong Huang
Xindong Yin
Taiyang Zhu
Shibing Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1511958

292 views

Review

Accepted on 09 Jan 2025

Advances in preclinical and clinical studies of oncolytic virus combination therapy

in Cancer Immunity and Immunotherapy

Wenlong Du
jintong Na
liping Zhong
pumin zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1545542

Original Research

Published on 09 Jan 2025

DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway

in Cancer Immunity and Immunotherapy

Rui Zhao
Mengran Wang
Zeyu Wu
Panpan Zhao
Huiling Dong
Yue Su
Chenghui Zhao
Min Qi
Shizhang Ling
Xiaochun Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1528454

236 views

Case Report

Accepted on 08 Jan 2025

Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: A case report

in Cancer Immunity and Immunotherapy

Xuejun Jiang
Zujin Ji
Fangjun Yuan
Xinyi Lei
Peng Li
Yong Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1465645

Original Research

Accepted on 31 Dec 2024

Targeting NANOS1 in Triple-Negative Breast Cancer: Synergistic Effects of Digoxin and PD-1 Inhibitors in Modulating the Tumor Immune Microenvironment

in Cancer Immunity and Immunotherapy

Tangyi Wang
Yadian Lei
Jingwei Sun
Li Wang
Yuxin Lin
Zhijing Wu
Shoude Zhang
Chengzhu Cao
Haiyan Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1536406

217 views

Original Research

Accepted on 30 Dec 2024

Potential biomarkers for predicting the risk of thyroid cancer in immunosenescence: a population-based and externally validated multi omics study

in Cancer Immunity and Immunotherapy

Qian Li
Yuanyuan Zhao
Jiawei Yan
Chao He

Frontiers in Oncology

doi 10.3389/fonc.2024.1525767

121 views

Case Report

Published on 24 Dec 2024

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

in Cancer Immunity and Immunotherapy

Ying Sun
Guanghui Yang
Ruijie Sun
Fangli Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1462993

322 views

Case Report

Published on 24 Dec 2024

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges

in Cancer Immunity and Immunotherapy

Chengwei Jin
Hong Ge
Dongsheng Hou
Jing Li
Mingming Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1515240

540 views

Navigation group

Articles

Long-term disease control in dedifferentiated liposarcoma: a case report on trabectedin priming followed by PD-1 inhibition

Unveiling the Multifaceted Role of CXCL1 in Ovarian Cancer, Atherosclerosis, and Valvular Calcification: An Integrated Bioinformatics Perspective

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

Low Dose Radiation Reverses Pembrolizumab Resistance in Melanoma: Case Report

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to Tislelizumab: a case report

Dramatic Response of Advanced Pulmonary Sarcomatoid Carcinoma to Tislelizumab Combined with Anlotinib: A Case Report

Development and validation of a machine learning model to predict the risk of lymph node metastasis in early-stage supraglottic laryngeal cancer

CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment

Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker

Advances in preclinical and clinical studies of oncolytic virus combination therapy

DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway

Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: A case report

Targeting NANOS1 in Triple-Negative Breast Cancer: Synergistic Effects of Digoxin and PD-1 Inhibitors in Modulating the Tumor Immune Microenvironment

Potential biomarkers for predicting the risk of thyroid cancer in immunosenescence: a population-based and externally validated multi omics study

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges